Natural killer cell neoplasms: A distinctive group of highly aggressive lymphomas/leukemias

Seminars in Hematology

Volumn 40, Issue 3, 2003, Pages 221-232

  Cheung, Michael M C ^a   Chan, John K C ^b   Wong, Kit Fai ^b  

^a QUEEN ELIZABETH HOSPITAL   (Hong Kong)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CD2 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD57 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 2 RECEPTOR; MEMBRANE ANTIGEN;

APOPTOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CELL DEATH; CELL INVASION; CYTOPATHOLOGY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; GASTROINTESTINAL TRACT; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOPATHOLOGY; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MULTIPLE ORGAN FAILURE; NATURAL KILLER CELL; NOSE CAVITY; NOSE MUCOSA; NOSE OBSTRUCTION; POOR GENERAL CONDITION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; REVIEW; SKIN; SOFT TISSUE; SURVIVAL RATE; SURVIVAL TIME; TESTIS;

EID: 0038491282     PISSN: 00371963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0037-1963(03)00136-7     Document Type: Article

References (99)

1. Abe Y, Muta K, Ohshima K, et al: Subcutaneous panniculitis by Epstein-Barr virus-infected natural killer (NK) cell proliferation terminating in aggressive subcutaneous NK cell lymphoma. Am J Hematol 64:221-225, 2000
2. Arber DA, Weiss LM, Albujar PF, et al: Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17:392-399, 1993
3. Chan JK: Natural killer cell neoplasms. Anat Pathol 3:77-145, 1998
4. Chan JK, Ng CS, Lau WH, et al: Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 11:418-429, 1987
5. Chan JK, Sin VC, Wong KF, et al: Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89:4501-4513, 1997
6. Chan JK, Tsang WY, Hui PK, et al: T- and T/natural killer-cell lymphomas of the salivary gland: A clinicopathologic, immunohistochemical and molecular study of six cases. Hum Pathol 28:238-245, 1997
7. Chan JK, Tsang WY, Lau WH, et al: Aggressive T/natural killer cell lymphoma presenting as testicular tumor. Cancer 77:1198-1205, 1996
8. Chan JK, Tsang WY, Pau MY: Discordant CD3 expression in lymphomas when studied on frozen and paraffin sections. Hum Pathol 26:1139-1143, 1995
9. Chan JKC, Jaffe ES, Ralfkiaer E: Blastic NK-cell lymphoma, in Jaffe ES, Harris NL, Stein H (eds): Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon, France, IARC Press, 2001, pp 214-215
10. Chan JKC, Jaffe ES, Ralfkiaer E: Extranodal NK/T-cell lymphoma, nasal type, in Jaffe ES, Harris NL, Stein H, et al (eds): Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. Lyon, France, IARC Press, 2001, pp 204-207
11. Chan JKC, Ng CS, Tsang WY: Nasal/nasopharyngeal lymphomas: An immunohistochemical analysis of 57 cases on frozen tissues. Mod Pathol 6:87A, 1993 (abstr)
12. Chan JKC, Wong KF, Jaffe ES, et al: Aggressive NK-cell leukemia, in Jaffe ES, Harris NL, Stein H, et al (eds): Pathology and Genetics, Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours, Lyon, France, IARC Press, 2001, 198-200
13. Cheung MM, Chan JK, Lau WH, et al: Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features, tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol 16:70-77, 1998
14. Cheung MM, Chan JK, Lau WH, et al: Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality. Int J Radiat Oncol Biol Phys 54:182-190, 2002
15. Cheung MM, Chan JK, Wong KH: Early stage nasal NK/T cell lymphoma: Preliminary result of intensifying treatment with concurrent chemo-radiation and high dose chemotherapy. Ann Oncol 12:82, 2002 (suppl 2, abstr)
16. Chinen K, Kaneko Y, Izumo T, et al: Nasal natural killer cell/t-cell lymphoma showing cellular morphology mimicking normal lymphocytes. Arch Pathol Lab Med 126:602-605, 2002
17. Chou WC, Chiang IP, Tang JL, et al: Clonal disease of natural killer large granular lymphocytes in Taiwan. Br J Haematol 103:1124-1128, 1998
18. Cuadra-Garcia I, Proulx GM, Wu CL, et al: Sinonasal lymphoma: A clinicopathologic analysis of 58 cases from the Massachusetts General Hospital. Am J Surg Pathol 23:1356-1369, 1999
19. Dukers DF, Vermeer MH, Jaspars LH, et al: Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype. J Clin Pathol 54:224-228, 2001
20. Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, et al: Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 11:754-761, 1998
21. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87:1466-1473, 1996
22. Engellenner W, Golightly M: Large granular lymphocyte leukemia. Lab Med 22:454-456, 1991
23. Fukuda J, Yoshihara T, Arai Y, et al: Nasal NK-cell lymphoma. Rinsho Ketsueki 35:588-592, 1994
24. Gaal K, Sun NC, Hernandez AM, et al: Sinonasal NK/T-cell lymphomas in the United States. Am J Surg Pathol 24:1511-1517, 2000
25. Gelb AB, van de Rijn M, Regula DP Jr, et al: Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia. Hum Pathol 25:953-960, 1994
26. Goodlad JR, Fletcher CDM, Chan JKC, et al: Primary soft tissue lymphoma: An analysis of 37 cases. J Pathol 179:42A, 1996 (suppl, abstr)
27. Haedicke W, Ho FC, Chott A, et al: Expression of CD94/NKG2A and killer immunoglobulin-like receptors in NK cells and a subset of extranodal cytotoxic T-cell lymphomas. Blood 95:3628-3630, 2000
28. Harris NL, Jaffe ES, Diebold J, et al: The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol 10:1419-1432, 1999
29. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
30. Hart DN, Baker BW, Inglis MJ, et al: Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 79:2116-2123, 1992
31. + blastic tumors of skin. Blood (in press)
32. Ho FC, Srivastava G, Loke SL, et al: Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol Oncol 8:271-281, 1990
33. Imamura N, Kusunoki Y, Kawa-Ha K, et al: Aggressive natural killer cell leukaemia/lymphoma: Report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. Br J Haematol 75:49-59, 1990
34. Ishihara S, Ohshima K, Tokura Y, et al: Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res 88:82-87, 1997
35. Ishihara S, Yabuta R, Tokura Y, et al: Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease. Int J Hematol 72:223-228, 2000
36. Jaffe ES, Chan JK, Su IJ, et al: Report of the Workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 20:103-111, 1996
37. Katoh A, Ohshima K, Kanda M, et al: Gastrointestinal T cell lymphoma: Predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells. Leuk Lymphoma 39:97-111, 2000
38. Kawa-Ha K, Ishihara S, Ninomiya T, et al: CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84:51-55, 1989
39. Kern WF, Spier CM, Hanneman EH, et al: Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement. Blood 79:2432-2437, 1992
40. Kim GE, Cho JH, Yang WI, et al: Angiocentric lymphoma of the head and neck: Patterns of systemic failure after radiation treatment. J Clin Oncol 18:54-63, 2000
41. Kim WS, Song SY, Ahn YC, et al: CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma? Ann Oncol 12:349-352, 2001
42. Kim YJ, Park QE, Kim SH, et al: Clinicopathologic findings of aggressive NK cell leukemia. Korean J Pathol 36:95, 2002 (suppl, abstr)
43. + NK lymphomas: Clinicopathological features and prognosis. Br J Haematol 97:821-829, 1997
44. Kwong YL, Wong KF, Chan LC, et al: Large granular lymphocyte leukemia. A study of nine cases in a Chinese population. Am J Clin Pathol 103:76-81, 1995
45. Lei KI, Chan LY, Chan WY, et al: Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies. Br J Haematol 111:239-246, 2000
46. Lei KI, Chan LY, Chan WY, et al: Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma. Clin Cancer Res 8:29-34, 2002
47. Lei KI, Suen JJ, Hui P, et al: Primary nasal and nasopharyngeal lymphomas: A comparative study of clinical presentation and treatment outcome. Clin Oncol (R Coll Radiol) 11:379-387, 1999
48. Leroux D, Mugneret F, Callanan M, et al: CD4(+), CD56(+) DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: A study of 21 cases by the Groupe Francais de Cytogenetique Hematologique. Blood 99:4154-4159, 2002
49. Li YX, Coucke PA, Li JY, et al: Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer 83:449-456, 1998
50. Liang R, Chen F, Lee CK, et al: Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplant 19:91-93, 1997
51. Logsdon MD, Ha CS, Kavadi VS, et al: Lymphoma of the nasal cavity and paranasal sinuses: Improved outcome and altered prognostic factors with combined modality therapy. Cancer 80:477-488, 1997
52. Loughran TP: Clonal diseases of large granular lymphocytes. Blood 82:1-14, 1993
53. Lymphoma Study Group of Japanese Pathologists: The World Health Organization Classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Pathol Int 50:696-702, 2000
54. Martin AR, Chan WC, Perry DA, et al: Aggressive natural killer cell lymphoma of the small intestine. Mod Pathol 8:467-472, 1995
55. Misago N, Ohshima K, Aiura S, et al: Primary cutaneous T-cell lymphoma with an angiocentric growth pattern: Association with Epstein-Barr virus. Br J Dermatol 135:638-643, 1996
56. Miyamoto T, Yoshino T, Takehisa T, et al: Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: Clinicopathological findings of four cases. Br J Dermatol 139:481-487, 1998
57. Mori KL, Egashira M, Oshimi K: Differentiation stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. Br J Haematol 115:225-228, 2001
58. Mori N, Yamashita Y, Tsuzuki T, et al: Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection. Histopathology 37:363-371, 2000
59. Mori N, Yatabe Y, Oka K, et al: Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. Am J Pathol 149:699-705, 1996
60. +, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 19:2179-2188, 2001
61. Nagafuji K, Fujisaki T, Arima F, et al: L-asparaginase induced durable remission of relapsed nasal NK/T-cell lymphoma after autologous peripheral blood stem cell transplantation. Int J Hematol 74:447-450, 2001
62. Nakamura S, Katoh E, Koshikawa T, et al: Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol Int 47:38-53, 1997
63. Nakamura S, Suchi T, Koshikawa T, et al: Clinicopathologic study of CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Am J Surg Pathol 19:284-296, 1995
64. Ng CS, Chan JK, Cheng PN, et al: Nasal T-cell lymphoma associated with hemophagocytic syndrome. Cancer 58:67-71, 1986
65. Ng CS, Chan JK, Lo ST: Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 18:1257-1262, 1987
66. + putative natural killer cell lymphomas: Production of cytolytic effectors and related proteins mediating tumor cell apoptosis? Hum Pathol 28: 1276-1282, 1997
67. Obama K, Tara M, Niina K: L-asparaginase induced complete remission in Epstein-Barr virus positive, multidrug resistant, cutaneous T-cell lymphoma. Int J Hematol 69:260-262, 1999
68. Ohno T, Yamaguchi M, Oka K, et al: Frequent expression of CD3 epsilon in CD3 (Leu 4)-negative nasal T-cell lymphomas. Leukemia 9:44-52, 1995
69. Okuda T, Sakamoto S, Deguchi T, et al: Hemophagocytic syndrome associated with aggressive natural killer cell leukemia. Am J Hematol 38:321-323, 1991
70. Ooi GC, Chim CS, Liang R, et al: Nasal T-cell/natural killer cell lymphoma: CT and MR imaging features of a new clinicopathologic entity. AJR Am J Roentgenol 174:1141-1145, 2000
71. Oshimi K: Lymphoproliferative disorders of natural killer cells. Int J Hematol 63:279-290, 1996
72. Oshimi K, Yamada O, Kaneko T, et al: Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 7:782-788, 1993
73. Petrella T, Delfau-Larue MH, Caillot D, et al: Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum Pathol 27:827-833, 1996
74. Rabbani GR, Phyliky RL, Tefferi A: A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 106:960-966, 1999
75. Ribrag V, Ell Hajj M, Janot F, et al: Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx. Leukemia 15:1123-1126, 2001
76. Rodriguez J, Romaguera JE, Manning J, et al: Nasal-type T/NK lymphomas: A clinicopathologic study of 13 cases. Leuk Lymphoma 39:139-144, 2000
77. Rudiger T, Weisenburger DD, Anderson JR, et al: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): Results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 13:140-149, 2002
78. Sakata K, Hareyama M, Ohuchi A, et al: Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol 36:307-311, 1997
79. Sato K, Kimura F, Nakamura Y, et al: An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand. Br J Haematol 94:379-382, 1996
80. Shikama N, Izuno I, Oguchi M, et al: Clinical stage IE primary lymphoma of the nasal cavity: Radiation therapy and chemotherapy. Radiology 204:467-470, 1997
81. Shimodaira S, Ishida F, Kobayashi H, et al: The detection of clonal proliferation in granular lymphocyte-proliferative disorders of natural killer cell lineage. Br J Haematol 90:578-584, 1995
82. Siu LL, Chan JK, Kwong YL: Natural killer cell malignancies: Clinicopathologic and molecular features. Histol Histopathol 17:539-554, 2002
83. Siu LL, Chan JKC, Wong KF, et al: Specific patterns of gene methylation in natural killer cell lymphoma: p73 is consistently involved. Am J Pathol 160:59-66, 2002
84. Suzumiya J, Takeshita M, Kimura N, et al: Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 83:2255-2260, 1994
85. Takahashi N, Miura I, Chubachi A, et al: A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated hemophagocytic syndrome with special reference to nasal and nasal-type NK/T-cell lymphoma. Int J Hematol 74:303-308, 2001
86. Takeshita M, Kimura N, Suzumiya J, et al: Angiocentric lymphoma with granulomatous panniculitis in the skin expressing natural killer cell and large granular T-cell phenotypes. Virchows Arch 425:499-504, 1994
87. + NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. Am J Clin Pathol 113:201-211, 2000
88. Tanaka M, Suda T, Haze K, et al: Fas ligand in human serum. Nat Med 2:317-322, 1996
89. Tefferi A: Chronic natural killer cell lymphocytosis. Leuk Lymphoma 20:245-248, 1996
90. Tefferi A, Li CY, Witzig TE, et al: Chronic natural killer cell lymphocytosis: A descriptive clinical study. Blood 84:2721-2725, 1994
91. Tien HF, Su IJ, Tang JL, et al: Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. Br J Haematol 97:621-625, 1997
92. Wong KF: Genetic changes in natural killer cell neoplasms. Leuk Res 26:977-978, 2002
93. Wong KF, Chan JK, Ng CS: CD56 (NCAM)-positive malignant lymphoma. Leuk Lymphoma 14:29-36, 1994
94. Wong KF, Chan JK, Ng CS, et al: CD56 (NKH1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 23:798-804, 1992
95. Wong KF, Zhang YM, Chan JK: Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia - Is there a consistent pattern? Leuk Lymphoma 34:241-250, 1999
96. Yamaguchi M, Kita K, Miwa H, et al: Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer 76:2351-2356, 1995
97. Yamaguchi M, Shoko O, Yoshihito N: Treatment outcome of nasal NK-cell lymphoma: A report of 12 consecutively diagnosed cases and a review of the literature. J Clin Exp Hematopathol 41:93-99, 2001
98. Yong W, Zhang Y, Zheng W: The efficacy of L-asparaginase in the treatment of refractory midline peripheral T-cell lymphoma. Zhonghua Xue Ye Xue Za Zhi 21:577-579, 2000
99. Yong W, Zheng W, Zhang Y, et al: Clinical characteristics and treatment of midline nasal and nasal type NK/T cell lymphoma. Zhonghua Yi Xue Za Zhi 81:773-775, 2001